- Home
- Companies
- azerbaijan
- chemotherapy
Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Waste and Recycling
- Water and Wastewater
- Air and Climate
- Mining
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Agriculture
- Monitoring and Testing
- Environmental
- Health and Safety
- University / Academia / Research
- Government
- Manufacturing, Other
- Energy
- Construction & Construction Materials
Chemotherapy Suppliers Serving Azerbaijan
95 companies found
Premium
based inMaple Lake, MINNESOTA (USA)
As the leading manufacturer of ozone machines for medical waste, Clean Waste Systems is pushing the medical waste industry forward with our revolutionary alternative to incineration and autoclave processing. We’re experts in the use of ozone ...
based inBarbengo – Lugano, SWITZERLAND
With over 40 years in the pharmaceutical industry, Cerbios is a privately held company with headquarter in Barbengo-Lugano, Switzerland, specialising in the development and manufacture of both chemical and biological APIs for its partners worldwide. ...
For over 40 years, Cerbios has been a worldwide market leader for the manufacture and supply of reduced Folates. Folates are a class of water soluble compounds belonging to the Vitamin B complex which are essential for a number of metabolic ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
Zymeworks’ lead product candidate, zanidatamab, is a HER2-targeted bispecific antibody developed using Zymeworks proprietary Azymetric platform. Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based inFranklin Lakes, NEW JERSEY (USA)
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research ...
Deliver the widest range of care you’ll find in one infusion pump. Programmable for antibiotics, chemotherapy, TPN and PCA, the BodyGuard 323™ pump equips you with many therapeutic options. The compact, ...
based inxiamen, CHINA
XIAMEN SPACEGEN Co., Ltd. is a high-tech molecular diagnostic biology enterprise integrating R&D, production, sales and service. The company leads technological innovation guided by clinical needs ,providing high-quality and accessible molecular ...
Detection Gene:7 MGMT promoter region methylated loci. Detection Significance:Predicting the therapeutic effect of Temozolomide;Auxiliary prognosis of patients with ...
based inSherbrooke, QUEBEC (CANADA)
At IBIOM, we believe that the right posture makes all the difference. That’s why, for over 40 years, we have been dedicated to improving patients’ and healthcare professionals’ comfort and safety by manufacturing and distributing ergonomic medical ...
Designed for patient comfort during dialysis, oncology, and chemotherapy treatments. For treatments that require substantial chair time, there is no better option for patient comfort than the TRIAD. Developed and adjusted with ...
based inShanghai, CHINA
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide ...
We expect to develop ES028 as a monotherapy to provide an “eat-me” signal that can induce full activation of macrophage phagocytosis towards CLDN18.2-expressing tumors, which include gastric cancer and pancreatic cancer. Additionally, ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
based inAlta Loma, CALIFORNIA (USA)
Specializing in autoclave bags and autoclavable cart liners, Pacific Medical Specialties, LLC is a certified minority-owned, small business. We also offer disposable surgical cart covers, biohazard red infectious waste bags, sterility maintenance ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
C6 Ceramide exhibits multiple anti-cancer properties including cell cycle arrest, Apoptosis, inhibition of tumor growth and enhances the effects of chemotherapy in drug-resistant cancer cells. C6-ceramide can be used as an adjuvant ...
based inSalt Lake City, UTAH (USA)
PYREXAR Medical is the pioneer and worldwide market leader in the development and manufacture of innovative and highly effective hyperthermia treatment systems with established global distribution. PYREXAR Hyperthermia treatments increase the ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
based inCham, SWITZERLAND
The global healthcare system is fundamentally changing - advances in technology such as robotics and artificial intelligence as well as rising consumer expectations are driving a global shift in the healthcare landscape. Similarly to the ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
based inStockholm, SWEDEN
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical ...
Efficient care management for radiation oncology. Keep care teams informed and work flowing smoothly with an integrated information system. Elekta Care Management software helps you efficiently manage all aspects of your radiation oncology program. ...
based inBarcelona, SPAIN
Global manufacturer of high quality IV infusion devices. Since 1979 we have been manufacturing single-use IV infusion devices, delivering the best solutions through innovation, quality, and engagement of the best talent. We are a worldwide leader in ...
DOSI-FUSER® is designed for safe outpatient infusion therapy. It promotes patient recovery and improves the quality of life by increasing patient freedom and removing the inconvenience of electronic ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
